1. Home
  2. ADMA vs KTOS Comparison

ADMA vs KTOS Comparison

Compare ADMA & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • KTOS
  • Stock Information
  • Founded
  • ADMA 2004
  • KTOS 1994
  • Country
  • ADMA United States
  • KTOS United States
  • Employees
  • ADMA N/A
  • KTOS N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • KTOS Military/Government/Technical
  • Sector
  • ADMA Health Care
  • KTOS Industrials
  • Exchange
  • ADMA Nasdaq
  • KTOS Nasdaq
  • Market Cap
  • ADMA 3.8B
  • KTOS 4.2B
  • IPO Year
  • ADMA N/A
  • KTOS 1999
  • Fundamental
  • Price
  • ADMA $16.90
  • KTOS $34.38
  • Analyst Decision
  • ADMA Strong Buy
  • KTOS Buy
  • Analyst Count
  • ADMA 4
  • KTOS 11
  • Target Price
  • ADMA $21.25
  • KTOS $28.40
  • AVG Volume (30 Days)
  • ADMA 2.5M
  • KTOS 2.4M
  • Earning Date
  • ADMA 02-26-2025
  • KTOS 02-11-2025
  • Dividend Yield
  • ADMA N/A
  • KTOS N/A
  • EPS Growth
  • ADMA N/A
  • KTOS N/A
  • EPS
  • ADMA 0.28
  • KTOS 0.10
  • Revenue
  • ADMA $382,809,000.00
  • KTOS $1,127,000,000.00
  • Revenue This Year
  • ADMA $66.90
  • KTOS $12.24
  • Revenue Next Year
  • ADMA $13.76
  • KTOS $12.20
  • P/E Ratio
  • ADMA $60.29
  • KTOS $341.31
  • Revenue Growth
  • ADMA 63.39
  • KTOS 11.30
  • 52 Week Low
  • ADMA $5.02
  • KTOS $16.78
  • 52 Week High
  • ADMA $23.64
  • KTOS $35.66
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 48.60
  • KTOS 66.07
  • Support Level
  • ADMA $15.70
  • KTOS $32.40
  • Resistance Level
  • ADMA $16.60
  • KTOS $34.26
  • Average True Range (ATR)
  • ADMA 0.69
  • KTOS 1.26
  • MACD
  • ADMA 0.10
  • KTOS -0.17
  • Stochastic Oscillator
  • ADMA 77.17
  • KTOS 60.86

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

Share on Social Networks: